[{"address1": "2222 Ponce de Leon Blvd.", "address2": "Floor 3", "city": "Coral Gables", "state": "FL", "zip": "33134", "country": "United States", "phone": "786 629 1376", "website": "https://www.relmada.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.", "fullTimeEmployees": 17, "companyOfficers": [{"maxAge": 1, "name": "Dr. Sergio  Traversa M.B.A., Pharm.D.", "age": 64, "title": "CEO & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 1800723, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maged S. Shenouda M.B.A., R.Ph.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 993750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul E. Kelly M.B.A.", "age": 67, "title": "COO & Director", "yearBorn": 1957, "fiscalYear": 2024, "totalPay": 872780, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Charles S. Ence CPA, M.B.A.", "age": 59, "title": "Chief Accounting & Compliance Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 983039, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Gina  DiGuglielmo", "title": "VP & Head of Clinical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A.", "age": 57, "title": "Chief Medical Officer of Urology", "yearBorn": 1967, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew  Cutler", "title": "Senior Clinical Development Advisor", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard M. Mangano Ph.D.", "age": 74, "title": "Consultant", "yearBorn": 1950, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 10, "compensationRisk": 10, "shareHolderRightsRisk": 4, "overallRisk": 9, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.32, "open": 2.31, "dayLow": 2.19, "dayHigh": 2.37, "regularMarketPreviousClose": 2.32, "regularMarketOpen": 2.31, "regularMarketDayLow": 2.2, "regularMarketDayHigh": 2.37, "payoutRatio": 0.0, "beta": 0.918, "forwardPE": -1.1243781, "volume": 54698, "regularMarketVolume": 54486, "averageVolume": 736718, "averageVolume10days": 158950, "averageDailyVolume10Day": 158950, "bid": 2.18, "ask": 2.3, "bidSize": 1, "askSize": 1, "marketCap": 75013064, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 3.672, "allTimeHigh": 80.0, "allTimeLow": 0.24, "fiftyDayAverage": 1.77874, "twoHundredDayAverage": 0.79793, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 54393524, "profitMargins": 0.0, "floatShares": 23007105, "sharesOutstanding": 33191622, "sharesShort": 562426, "sharesShortPriorMonth": 711326, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.016900001, "heldPercentInsiders": 0.18851, "heldPercentInstitutions": 0.34312, "shortRatio": 1.21, "shortPercentOfFloat": 0.0173, "impliedSharesOutstanding": 33191622, "bookValue": 0.481, "priceToBook": 4.6985445, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -67809016, "trailingEps": -2.2, "forwardEps": -2.01, "lastSplitFactor": "1:4", "lastSplitDate": 1569801600, "52WeekChange": -0.3391813, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 2.26, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 20619540, "totalCashPerShare": 0.621, "totalDebt": 0, "quickRatio": 4.016, "currentRatio": 4.108, "returnOnAssets": -0.95669997, "returnOnEquity": -1.7512399, "freeCashflow": -25782928, "operatingCashflow": -49924936, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RLMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1761954391, "regularMarketTime": 1761940800, "shortName": "Relmada Therapeutics, Inc.", "longName": "Relmada Therapeutics, Inc.", "marketState": "CLOSED", "epsTrailingTwelveMonths": -2.2, "epsForward": -2.01, "epsCurrentYear": -1.15, "priceEpsCurrentYear": -1.9652175, "fiftyDayAverageChange": 0.48125994, "fiftyDayAverageChangePercent": 0.27056226, "twoHundredDayAverageChange": 1.46207, "twoHundredDayAverageChangePercent": 1.8323287, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1403271000000, "postMarketChangePercent": -4.4247746, "postMarketPrice": 2.16, "postMarketChange": -0.099999905, "regularMarketChange": -0.0599999, "regularMarketDayRange": "2.2 - 2.37", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 736718, "fiftyTwoWeekLowChange": 2.02, "fiftyTwoWeekLowChangePercent": 8.416667, "fiftyTwoWeekRange": "0.24 - 3.672", "fiftyTwoWeekHighChange": -1.412, "fiftyTwoWeekHighChangePercent": -0.3845316, "fiftyTwoWeekChangePercent": -33.91813, "dividendDate": 1569801600, "earningsTimestamp": 1754596800, "earningsTimestampStart": 1762459200, "earningsTimestampEnd": 1762459200, "earningsCallTimestampStart": 1754598600, "earningsCallTimestampEnd": 1754598600, "isEarningsDateEstimate": true, "exchange": "NCM", "messageBoardId": "finmb_9070579", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.5862, "regularMarketPrice": 2.26, "displayName": "Relmada Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]